Job Watch

Paramount Recruitment: Director of Computational Biology

New Scientist - Bioinformatics - Mon, 2019-08-19 11:37
Negotiable: Paramount Recruitment: The Director of Bioinformatics will be involved with developing departmental strategy focussing on target identification, biomarkers, target validation and qualification of drug targets, focussing predominantly on cardio-metabolic diseases. Oxford, England
Categories: Job Watch

NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-349 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-346 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-347 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.

NIDA Program Project Grant Applications (P01 Clinical Trial Optional)

Funding Opportunity PAR-19-345 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) announces the availability of support for collaborative research by multi-disciplinary teams which is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches. The NIDA Program Projects funding opportunity will support research in which the funding of three or more highly meritorious projects as a group enriches both the component projects and the overall program to offer significant scientific advantages over supporting the same projects as individual research grants (i.e., synergy). For the duration of the award, each Program must consist of a minimum of three research projects focused on issues critical to advance the mission and goals of NIDA.

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)

Funding Opportunity PAR-19-348 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)

Funding Opportunity PAR-19-350 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication pilot interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Post Doctoral Fellow - Microbiology, Immunology and Cell Biology - WVU Research Corporation - Morgantown, WV

Indeed.com - Bioinformatics - Thu, 2019-08-15 18:05
Isolation and analysis of tumor infiltrating lymphocytes using multiplex single-cell analysis techniques. Perform manual or computer-assisted data analysis,…
From West Virginia University - Thu, 15 Aug 2019 22:05:54 GMT - View all Morgantown, WV jobs
Categories: Job Watch

F. Hoffmann-La Roche AG: Semantic Data Integrator

New Scientist - Bioinformatics - Thu, 2019-08-15 13:41
F. Hoffmann-La Roche AG: Roche has been taken a strategic effort across functions and sites to improve data quality and to make data FAIR (findable, accessible, interop Switzerland (CH)
Categories: Job Watch

Notice of Information: NIAAA Preclinical Medication Efficacy Testing Program

Notice NOT-AA-19-021 from the NIH Guide for Grants and Contracts

Hazardous Materials Worker Health and Safety Training (U45 Clinical Trial Not Allowed)

Funding Opportunity RFA-ES-19-003 from the NIH Guide for Grants and Contracts. NIEHS invites applications for cooperative agreements to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response. This funding opportunity announcement aims to prevent work-related harm through safety and health training. The training programs will transmit skills and knowledge to workers in how best to protect themselves and their communities from exposure to hazardous materials encountered during hazardous waste operations, hazardous materials transportation, environmental restoration of contaminated facilities or chemical emergency response. A variety of sites, such as those involved with chemical waste cleanup and remedial action and transportation-related chemical emergency response, may pose severe health and safety concerns to workers and the surrounding communities. These sites contain many hazardous substances, sometimes unknown, and often a site is uncontrolled. A major goal of the Worker Training Program (WTP) is to support institutional competency-building for the development and delivery of model training and education programs.

Paramount Recruitment: Senior Platform Programmer

New Scientist - Bioinformatics - Thu, 2019-08-15 09:29
Negotiable: Paramount Recruitment: Senior Platform Programmer - Bioinformatics Cambridge This is a great opportunity for an experienced programmer/developer to be involved in the techni Cambridge, England
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch